Compensation to patient [Regulatives / Guidelines]

posted by Pharma_88 – India, 2025-01-22 14:02 (511 d 15:52 ago) – Posting: # 24344
Views: 4,992

Dear All,

For Bioequivalence study conducted on patients, do we need to provide financial compensation to patients for the participation i.e. Housing or blood loss for Pharmacokinetic evaluation? any guideline from DCGI/ICMR or any regulatory body?

Regards,
Pharma_88

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
190 visitors (0 registered, 190 guests [including 22 identified bots]).
Forum time: 06:54 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5